Rem3dy Health raises £14M at £84M valuation for global 3D-printed vitamins push

Birmingham-based Rem3dy Health, the parent company behind personalised vitamin brand Nourished, has secured £14 million in new funding at an £84 million valuation. The round attracted a diverse group of global strategic investors, including Japanese beverage and wellness giant Suntory, Spanish brewing conglomerate Estrella Galicia, Indian healthcare provider Apollo Hospitals, and French pharmaceutical company UPSA. Future Planet Capital Regional, which manages the West Midlands Co-Investment Fund, also participated.

The fresh capital will fuel expansion into the United States, the MENA region, and India, while also powering a move into personalised health solutions for pets. Nourished products are already available in major UK retailers like Boots and Holland & Barrett, as well as more than 12,000 pharmacies across Europe. The company has sold over 53 million units since its launch in 2020, and its manufacturing process relies on 3D printing technology that has seen patent filings grow eight times faster than the average across all other sectors.

Founded in 2019 by registered nutritionist and serial entrepreneur Melissa Snover, Rem3dy Health uses patented 3D printing to create seven-layer vegan gummy stacks tailored to individual health goals. Customers fill out a questionnaire, and an algorithm recommends a combination from over 10 million possible nutrient configurations. The gummies are printed on demand at the company’s facility, which Snover says can produce 500,000 units per day.

“Securing this funding marks a major milestone for us,” Snover said. “Following a year of significant transformation and against one of the toughest fundraising environments in recent years, we are now in a strong position to scale globally.” The company previously raised approximately £19 million across earlier rounds, making this its largest single fundraise to date.

The investor mix underscores cross-sector interest in personalised nutrition, a category that has drawn increasing attention from strategic investors and athletes alike. Apollo Hospitals operates more than 70 hospitals and 6,000 pharmacies across India, giving Rem3dy Health a potential distribution partner in one of its target markets. Estrella Galicia’s participation signals that the Spanish company is looking beyond its core brewing and food business into health-adjacent categories.

Rupert Lyle, Investment Director at Future Planet Capital Regional and Fund Principal of the West Midlands Co-Investment Fund, said the round reflects the company’s trajectory. “When we first invested in Rem3dy, it was clear they were developing a truly disruptive brand and technology capable of revolutionising the global wellness industry,” Lyle said. Future Planet Capital Regional previously invested £500,000 in Rem3dy Health in September 2025 through the West Midlands Co-Investment Fund, a £25 million vehicle backed equally by the West Midlands Combined Authority and the West Midlands Pension Fund.

This round fits within a broader pattern of investor interest in companies that combine data, personalisation, and technology to deliver health services at scale. Whether Rem3dy Health’s 3D-printed gummies represent a genuine advance in nutritional science or a well-packaged consumer wellness product is a question the company will need to answer as it moves into markets where regulatory scrutiny of health claims tends to be more rigorous than in the UK.